Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

CME POST-TEST

CME POST-TEST Downloaded from https://pdfs.journals.lww.com/jaapa by BhDMf5ePHKZxZb3ruX4b9cKfbT5h3bp+v9gTtSlrchDWvVTxyN8Hif2P/rPZfAxb8td684/2m6Qj/1S0ZObgiiKJ9vD64yNdY1wI1G/v4gN3ti1fujtTJsg5898WZFuC on 02/23/2019 CME CME POST-TEST EXPIRATION DATE: AUGUST 2019 All post-tests must be completed and submitted online. Earn Category I CME Credit by reading both CME articles in this issue, reviewing the post-test, then taking the online test at http://cme.aapa.org. Successful completion is defi ned as a cumulative score of at least 70% correct. This material has been reviewed and is approved for 1 hour of clinical Category I (Preapproved) CME credit by the AAPA. OSTEOSARCOMA ALOPECIA 1. What is the typical presentation of osteosarcoma? 6. Which form of alopecia is known to be caused by a. A long bone fracture that is disproportionate to level of injury hormonal contraceptives? or trauma a. alopecia areata b. Several months of localized, intermittent pain that never fully b. androgenic alopecia resolves and is worse at night c. trichotillomania c. Sudden onset of pain and swelling that resolves within d. traction alopecia 24 hours d. Unilateral neuropathy and vascular compromise 7. Which form of progestin has the highest androgenic index? 2. What is the most common location of first occurrence of a. desogestrel osteosarcoma? b. drospirenon a. distal femur c. levonorgestrel b. distal humerus d. norethindrone c. proximal tibia d. proximal femur 8. A patient has been experiencing increased hair shedding for 6 months after starting a medium androgen index 3. A 14-year-old boy with a history of leg pain has a tender oral contraceptive. What is an appropriate management mass overlying the femur about 6 cm proximal to the strategy for this patient? superior margin of the patella. What is an appropriate a. Switch to a higher androgen index contraceptive first step in working up this clinical finding? b. Switch to a lower androgen index contraceptive a. excisional biopsy of the mass c. Switch to a progestin-only formulation b. MRI d. Wait for an additional 6 months of continued increased hair c. needle biopsy of the mass shedding before making any medication changes d. plain radiograph 9. Which diagnostic study is the most accurate method of 4. Which radiographic finding is pathognomonic for distinguishing the various forms of alopecia? osteosarcoma? a. hair pull test a. lytic bone lesions b. testosterone level b. “moth-eaten” appearance c. scalp biopsy c. sunburst pattern d. DHEA-S d. no radiographic fi ndings are pathognomonic for osteosarcoma 10. When should topical agents such as minoxidil or cortico- steroids be used to manage androgenic alopecia? 5. Which statement is correct about the use of ACP and a. If hair loss does not resolve after attempting low androgen ALP in the diagnosis of osteosarcoma? index contraceptives and/or nonhormal contraceptives such a. ACP is viewed as a reliable test for diagnosing osteosarcoma as the copper IUD in adults b. Topicals are fi rst-line agents and should precede all other b. ALP levels vary in adults over age 40 years, making it methods unreliable as a diagnostic test c. Topical agents play no role in the management of androgenic c. The ALP:ACP ratio is superior to either ALP or ACP alone in alopecia diagnosis of osteosarcoma d. If hair loss is minimally slowed with switching to low d. The ACP:ALP ratio is superior to either ALP or ACP alone in androgen index contraceptives, topicals should be added diagnosis of osteosarcoma for augmented response. JAAPA Journal of the American Academy of Physician Assistants www.JAAPA.com 25 Copyright © 2018 American Academy of Physician Assistants Downloaded from https://pdfs.journals.lww.com/jaapa by BhDMf5ePHKZxZb3ruX4b9cKfbT5h3bp+v9gTtSlrchDWvVTxyN8Hif2P/rPZfAxb8td684/2m6Qj/1S0ZObgiiKJ9vD64yNdY1wI1G/v4gN3ti1fujtTJsg5898WZFuC on 02/23/2019 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the American Academy of PAs Wolters Kluwer Health

CME POST-TEST

Journal of the American Academy of PAs , Volume 31 (8) – Aug 1, 2018

Loading next page...
 
/lp/wolters-kluwer-health/cme-post-test-IuBchDPrna
Publisher
Wolters Kluwer Health
ISSN
1547-1896
eISSN
0893-7400
DOI
10.1097/01.JAA.0000544246.11942.4f
Publisher site
See Article on Publisher Site

Abstract

Downloaded from https://pdfs.journals.lww.com/jaapa by BhDMf5ePHKZxZb3ruX4b9cKfbT5h3bp+v9gTtSlrchDWvVTxyN8Hif2P/rPZfAxb8td684/2m6Qj/1S0ZObgiiKJ9vD64yNdY1wI1G/v4gN3ti1fujtTJsg5898WZFuC on 02/23/2019 CME CME POST-TEST EXPIRATION DATE: AUGUST 2019 All post-tests must be completed and submitted online. Earn Category I CME Credit by reading both CME articles in this issue, reviewing the post-test, then taking the online test at http://cme.aapa.org. Successful completion is defi ned as a cumulative score of at least 70% correct. This material has been reviewed and is approved for 1 hour of clinical Category I (Preapproved) CME credit by the AAPA. OSTEOSARCOMA ALOPECIA 1. What is the typical presentation of osteosarcoma? 6. Which form of alopecia is known to be caused by a. A long bone fracture that is disproportionate to level of injury hormonal contraceptives? or trauma a. alopecia areata b. Several months of localized, intermittent pain that never fully b. androgenic alopecia resolves and is worse at night c. trichotillomania c. Sudden onset of pain and swelling that resolves within d. traction alopecia 24 hours d. Unilateral neuropathy and vascular compromise 7. Which form of progestin has the highest androgenic index? 2. What is the most common location of first occurrence of a. desogestrel osteosarcoma? b. drospirenon a. distal femur c. levonorgestrel b. distal humerus d. norethindrone c. proximal tibia d. proximal femur 8. A patient has been experiencing increased hair shedding for 6 months after starting a medium androgen index 3. A 14-year-old boy with a history of leg pain has a tender oral contraceptive. What is an appropriate management mass overlying the femur about 6 cm proximal to the strategy for this patient? superior margin of the patella. What is an appropriate a. Switch to a higher androgen index contraceptive first step in working up this clinical finding? b. Switch to a lower androgen index contraceptive a. excisional biopsy of the mass c. Switch to a progestin-only formulation b. MRI d. Wait for an additional 6 months of continued increased hair c. needle biopsy of the mass shedding before making any medication changes d. plain radiograph 9. Which diagnostic study is the most accurate method of 4. Which radiographic finding is pathognomonic for distinguishing the various forms of alopecia? osteosarcoma? a. hair pull test a. lytic bone lesions b. testosterone level b. “moth-eaten” appearance c. scalp biopsy c. sunburst pattern d. DHEA-S d. no radiographic fi ndings are pathognomonic for osteosarcoma 10. When should topical agents such as minoxidil or cortico- steroids be used to manage androgenic alopecia? 5. Which statement is correct about the use of ACP and a. If hair loss does not resolve after attempting low androgen ALP in the diagnosis of osteosarcoma? index contraceptives and/or nonhormal contraceptives such a. ACP is viewed as a reliable test for diagnosing osteosarcoma as the copper IUD in adults b. Topicals are fi rst-line agents and should precede all other b. ALP levels vary in adults over age 40 years, making it methods unreliable as a diagnostic test c. Topical agents play no role in the management of androgenic c. The ALP:ACP ratio is superior to either ALP or ACP alone in alopecia diagnosis of osteosarcoma d. If hair loss is minimally slowed with switching to low d. The ACP:ALP ratio is superior to either ALP or ACP alone in androgen index contraceptives, topicals should be added diagnosis of osteosarcoma for augmented response. JAAPA Journal of the American Academy of Physician Assistants www.JAAPA.com 25 Copyright © 2018 American Academy of Physician Assistants Downloaded from https://pdfs.journals.lww.com/jaapa by BhDMf5ePHKZxZb3ruX4b9cKfbT5h3bp+v9gTtSlrchDWvVTxyN8Hif2P/rPZfAxb8td684/2m6Qj/1S0ZObgiiKJ9vD64yNdY1wI1G/v4gN3ti1fujtTJsg5898WZFuC on 02/23/2019

Journal

Journal of the American Academy of PAsWolters Kluwer Health

Published: Aug 1, 2018

There are no references for this article.